Ovoca Bio PLC (LON:OVB) traded up 7.1% during trading on Wednesday . The company traded as high as GBX 11 ($0.14) and last traded at GBX 11.25 ($0.15), 128,712 shares changed hands during mid-day trading. The stock had previously closed at GBX 10.50 ($0.14).
The stock has a market capitalization of $9.18 million and a PE ratio of -5.63. The business has a 50 day moving average price of GBX 10.55 and a 200 day moving average price of GBX 9.66. The company has a debt-to-equity ratio of 4.80, a current ratio of 28.57 and a quick ratio of 23.52.
Ovoca Bio Company Profile (LON:OVB)
Ovoca Bio plc focuses on development and commercialization of novel product candidates for the treatment of female sexual dysfunctions. It is developing Libicore, a medication for treatment of female sexual dysfunction. The company was formerly known as Ovoca Gold plc and changed its name to Ovoca Bio plc in July 2018.
Featured Article: What are trading strategies for the 52-week high/low?
Receive News & Ratings for Ovoca Bio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ovoca Bio and related companies with MarketBeat.com's FREE daily email newsletter.